Could a daily pill free babies with rare diabetes from insulin shots?
NCT ID NCT00610038
First seen Nov 20, 2025 · Last updated May 19, 2026 · Updated 18 times
Summary
This study tested whether babies with a rare, permanent form of diabetes caused by specific gene changes could safely switch from daily insulin injections to an oral diabetes pill called glibenclamide. Nineteen infants and children took part. Researchers monitored their blood sugar and checked if the pill improved their development and thinking skills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Necker Hospital - Endocrinology Gynecology Pediatric unit
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.